Page last updated: 2024-08-25

honokiol and Idiopathic Parkinson Disease

honokiol has been researched along with Idiopathic Parkinson Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chan, MH; Chen, C; Tripathi, S1
Chan, MH; Chang, PC; Chen, C; Chen, HH; Chen, PM; Wey, SP1

Other Studies

2 other study(ies) available for honokiol and Idiopathic Parkinson Disease

ArticleYear
An expedient synthesis of honokiol and its analogues as potential neuropreventive agents.
    Bioorganic & medicinal chemistry letters, 2012, Jan-01, Volume: 22, Issue:1

    Topics: Biphenyl Compounds; Catalysis; Cell Death; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Drug Design; Humans; Lignans; Models, Chemical; Neuroblastoma; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Reactive Oxygen Species; Time Factors

2012
Therapeutic effects of honokiol on motor impairment in hemiparkinsonian mice are associated with reversing neurodegeneration and targeting PPARĪ³ regulation.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 108

    Topics: Animals; Biphenyl Compounds; Gliosis; Lignans; Longevity; Male; Mice; Motor Activity; NADPH Oxidases; Neostriatum; Nerve Degeneration; Oxidation-Reduction; Oxidopamine; Parkinson Disease; PPAR gamma

2018